ERBB2 and breast cancer: To discriminate the breast cancer subtypes, a total of 64 proteins were differentially expressed in TNBC compared to HER2+; these proteins are involved in angiogenesis (PLAU, ADAM9, and EPHA2), integrin-binding (ITGA5 and TIMP2), and cell motility (VIM and AXL).